TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced proposed amendments to its existing memorandum and articles of association, aiming to adopt a new version that supports the expansion of a paperless listing regime and the introduction of a new treasury shares regime. These changes are intended to optimize the company’s operations in line with recent consultations by the Stock Exchange of Hong Kong, pending shareholder approval at the upcoming annual general meeting.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, primarily involved in the healthcare industry, focusing on therapeutic solutions.
YTD Price Performance: 10.67%
Average Trading Volume: 2,325,112
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.09B
For a thorough assessment of 1477 stock, go to TipRanks’ Stock Analysis page.